Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Lachenal

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 20, 2018
Is 6 months of bedaquiline enough? Results from the compassionate use of bedaquiline in Armenia and GeorgiaC Hewison, M Bastard, N Khachatryan, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 31, 2020
Setting up pharmacovigilance based on available endTB Project data for bedaquilineN Lachenal, C Hewison, C Mitnick, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 31, 2020
Introducing new and repurposed TB drugs: the endTB experienceK J Seung, U Khan, F Varaine, et al.
Trials|September 26, 2021
Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trialL Guglielmetti, E Ardizzoni, M Atger, et al.
Trials|December 1, 2023
Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trialS B Patil, M Tamirat, K Khazhidinov, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 20, 2018
Is 6 months of bedaquiline enough? Results from the compassionate use of bedaquiline in Armenia and GeorgiaC Hewison, M Bastard, N Khachatryan, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 31, 2020
Setting up pharmacovigilance based on available endTB Project data for bedaquilineN Lachenal, C Hewison, C Mitnick, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 31, 2020
Introducing new and repurposed TB drugs: the endTB experienceK J Seung, U Khan, F Varaine, et al.
Trials|September 26, 2021
Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trialL Guglielmetti, E Ardizzoni, M Atger, et al.
Trials|December 1, 2023
Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trialS B Patil, M Tamirat, K Khazhidinov, et al.
Pageof 1